Of note, similar tumor growth inhibition was observed between shBecn1#1-derived tumor-bearing mice subjected to MitoX and TPX combination therapy and those subjected to MitoX monotherapy (p = 0.283, Figure 6A). The gene discussed is TPO; the disease is neoplasm.